SCHEMBL18156785

SCHEMBL18156785

c1ccc(-c2nc(-c3ccc4oc5c6c(ccc5c4c3)-c3ccccc3C63c4ccccc4-c4ccccc43)nc3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ATM Q13315 1/20 0.42
WHR1 P49842 1/20 0.35
NUDT1 P36639 2/20 0.33
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33
PTPRF P10586 2/20 0.33
PTPN2 P17706 2/20 0.33
PTPN1 P18031 2/20 0.33
ALOX5 P09917 2/20 0.33
ADORA2A P29274 1/20 0.33
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
HPGD P15428 2/20 0.32
NR1I3 Q14994 3/20 0.32
CYP1A2 P05177 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19132115 0.90 MEN1 (0.40) MEN1KMT2AATMWHR1NUDT1
SCHEMBL19824234 0.89 MEN1 (0.40) MEN1KMT2AATMWHR1NUDT1
SCHEMBL19132308 0.88 WHR1 (0.35) MEN1KMT2AATMWHR1GAA
SCHEMBL18156778 0.88 PIM1 (0.36) MEN1KMT2AATMMAPTGAA
SCHEMBL18156744 0.88 KMT2A (0.38) MEN1KMT2AATMWHR1NUDT1
SCHEMBL19132317 0.87 MEN1 (0.38) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18156834 0.85 MEN1 (0.41) MEN1KMT2AATMWHR1NUDT1
SCHEMBL19131645 0.84 PTPRF (0.35) MEN1KMT2AATMWHR1PTPRF
SCHEMBL22617654 0.84 KMT2A (0.47) MEN1KMT2AATMWHR1NUDT1
SCHEMBL16855598 0.84 MEN1 (0.42) MEN1KMT2AATMWHR1PTPRF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-11545634-B2 Heterocyclic spiro compounds MERCK PATENT GMBH (DE) 2023-01-03 US disclosed
EP-3708634-A1 HETEROCYCLIC SPIRO COMPOUNDS Merck Patent GmbH (DE) 2020-09-16 EP disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-08-20 US disclosed
EP-3083880-B1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-04-01 EP disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 MEN1 1660/4885KMT2A 3328/4885ATM 2905/4885
US-11545634-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 MEN1 1660/4885KMT2A 3328/4885ATM 2905/4885
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 MEN1 1660/4885KMT2A 3328/4885ATM 2905/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 MEN1 1660/4885KMT2A 3328/4885ATM 2905/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 MEN1 1660/4885KMT2A 3328/4885ATM 2905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.